Nexus AG: Very Strong Sales and Earnings Increase in 2020
In 2020, sales improved from KEUR 147,648 to KEUR 162,944 (+10.4%). The “Healthcare Software” division increased its sales from KEUR 139,597 to TEUR 154,532 (+10.7%), and the “Healthcare Service” division developed stronger than in the previous years with an increase from KEUR 8,051 in 2019 to KEUR 8,412 in 2020. The international share of total business volume was 45.6% (previous year: 46.7%) and amounted to KEUR 74,333 compared to KEUR 68,901 in the previous year.
Consolidated net income rose very sharply by 24.5% to KEUR 15,091 (previous year: KEUR 17,444), and consolidated earnings before interest and taxes (EBIT) rose by 14.2% to KEUR 19,915 thousand (previous year: KEUR 17,444. EBITA increased by 12.0% from TKEUR 21,676 (2019) to KEUR 24,284, and EBITDA increased by 7.9% to KEUR 36,640 (previous year: KEUR 33,947).
Operating cash flow, which was KEUR 30,947 in 2020 compared to KEUR 24,618 in the previous year (+25.7%), also showed a very strong increase. At the end of 2020, the company had cash resources at its disposal in the amount of KEUR 28,177 (previous year: KEUR 35,204). Nexus AG had equity capital amounting to KEUR 123,583 as of 31 December 2019 (previous year: KEUR 115,135). Consequently, the equity capital rate is 55.4% (previous year: 55.3%). This demonstrates that Nexus AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.